Sarah Bonnet

5PUBLICATIONS
54CO-AUTHORS
Innate immunityHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Cardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 15, 2025
Targeting SUMOylation Triggers IFN-β-dependent Activation of Patient and Allogenic NK Cells in Preclinical Models of Acute Myeloid Leukemia.

Rawan Hallal, Marion de Toledo, Denis Tempé

|Dec 06, 2024
Venetoclax-proteasome inhibitor-dexamethasone for unfit patients with blastic plasmacytoid dendritic cell neoplasm.

Sabine Khalife-Hachem, Arnaud Pages, Elie Akoury

|Oct 17, 2024
Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22<sup>+</sup> Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia.

Patrice Chevallier, Thibaut Leguay, Marc Delord

|Jun 20, 2024
Outcomes of acute myeloid leukemia patients who responded to venetoclax and azacitidine and stopped treatment.

Sylvain Garciaz, Pierre-Yves Dumas, Sarah Bertoli

|Nov 02, 2023
Extreme thrombocytosis with an aggressive evolution harboring a novel variant of calreticulin (CALR) in exon 3.

Sarah Bonnet, Serge Carillo, Baptiste Legrand

Pageof 1

Frequent Collaborators

2 joint publications

Guillaume Cartron

2 joint publications

Ludovic Gabellier

2 joint publications

Amine Belhabri

1 joint publications

Serge Carillo